Job Offers

"Tweeting Growers"

Top 5 -yesterday

Top 5 -last week

Top 5 -last month

Vestaron raises $40 million in Series B Financing

Vestaron announces its $40 million Series B Financing, led by Novo Holdings A/S. Novo Holdings joins continuing investors Anterra Capital, Cultivian Sandbox, Open Prairie Ventures, and Pangaea Ventures.

Vestaron has recently launched its first two products. Spear-T is designed for greenhouse use and controls all four major greenhouse pests – thrips, whiteflies, aphids and mites. Spear-Lep is designed for field use and controls lepidopteran pests. Both products are based on Vestaron’s Spear peptide, which has been assigned a novel nerve and muscular mode of action code by the Insect Resistance Action Committee.

The company will use the additional funds to support the commercialization of its Spear family of products, including expansion into new geographies, and to accelerate the development of its pipeline of additional peptide-based biopesticides.

Anna Rath, CEO at Vestaron said: “Vestaron is at the forefront of a revolutionary transition in crop protection, from an industry based predominantly on small molecule synthetics to one where biologic molecules with proven modes of action as well as great safety and environmental attributes will play a major role. This transition is being driven by the same factors that drove a similar transition in pharma – slowing innovation, increasing late-stage failures and thus development costs – as well as factors specific to crop protection including resistance of pests to existing solutions, environmental and worker safety issues, and consumer awareness of and focus on food safety and quality.”

Anders Spohr, Senior Director at Novo Holdings commented: “This is Novo Holdings’ first investment in biocontrols, specifically, and agtech more broadly. We believe that Vestaron’s platform has the potential to make a positive and meaningful impact on agriculture, the environment and society. We have deep conviction about Vestaron’s prospects and look forward to supporting the company and its team going forward.”

Phil Austin, Partner at Anterra Capital added: “In our time as investors, we have seen Vestaron overcome key technical hurdles. Having now demonstrated its ability to successfully commercialize its first peptide-based bioinsecticide, and with the strength of its pipeline and backing of such a strong investor syndicate, we believe Vestaron is well-positioned to become a major player in the crop protection industry.”

For more information:

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

© 2021

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber